Company Encyclopedia
View More
name
ADICON HOLDINGS
09860.HK
Adicon Holdings Limited, an investment holding company, provides medical testing services in the People’s Republic of China. The company offers medical diagnostic testing services; testing services for research and development projects; and research and clinical trial services. It also engages in the trading of medical testing equipment; and sale of medical products. The company was founded in 2004 and is headquartered in Hangzhou, the People’s Republic of China.
55.86 B
09860.HKMarket value -Rank by Market Cap -/-

Financial Score

19/11/2025 Update
D
Health Care ServicesIndustry
Industry Ranking20/29
Industry medianC
Industry averageC
Score Analysis
Peer Comparison
  • Criteria
    Rating
  • Profit ScoreD
    • ROE-1.59%D
    • Profit Margin-1.00%D
    • Gross Margin35.77%C
  • Growth ScoreD
    • Revenue YoY-12.71%E
    • Net Profit YoY-112.17%E
    • Total Assets YoY-1.46%D
    • Net Assets YoY-5.25%D
  • Cash ScoreE
    • Cash Flow Margin-9961.43%E
    • OCF YoY-12.71%E
  • Operating ScoreB
    • Turnover0.59B
  • Debt ScoreD
    • Gearing Ratio60.69%D

Valuation analysis

portai
P/E
1Y
3Y
5Y
10Y
P/E
-
Industry Ranking
-/-
  • P/E
  • Price
  • High
  • Median
  • Low
P/B
1Y
3Y
5Y
10Y
P/B
-
Industry Ranking
-/-
  • P/B
  • Price
  • High
  • Median
  • Low
P/S
1Y
3Y
5Y
10Y
P/S
-
Industry Ranking
-/-
  • P/S
  • Price
  • High
  • Median
  • Low
Dividend Yield
1Y
3Y
5Y
10Y
Dividend Yield
-
Industry Ranking
-/-
  • Dividend Yield
  • Price
  • High
  • Median
  • Low

Institutional View & Shareholder

Analyst Ratings

Rating
Percentage
    • Price
      --
    • Highest
      --
    • Lowest
      --
    News
    View More

    Top 10 HK Stock Losers (11.14)

    PONY-W(02026) fell 13.89%, with a trading turnover 276.2 Million HKD, and a year-to-date fell 33.1%. VTECH HOLDINGS(00303) fell 12.11%, with a trading turnover 344.9 Million HKD, and a year-to-date rose 19.2%. CKLIFE SCIENCES(00775) fell 11.88%, with a trading turnover 62.7 Million HKD, and a year-to-date rose 117.1%.

    LB Select·
    HK
    02026
    +4.35%
    HK
    00303
    -0.08%
    HK
    00775
    -1.15%
    LB Select·
    HK
    02026
    +4.35%
    HK
    00303
    -0.08%
    HK
    00775
    -1.15%

    JSR Life Sciences Enters Definitive Agreement to Transfer Crown Bioscience to Adicon Holdings Limited

    JSR Life Sciences has entered a definitive agreement to transfer Crown Bioscience to Adicon Holdings Limited, a clinical laboratory provider in China. This strategic move aims to enhance Crown Bioscience's growth in translational oncology, allowing it to operate independently under Adicon's ownership. The transaction is expected to close in 2026, with Crown continuing as a subsidiary of JSR until then. Adicon's expertise and resources are anticipated to support Crown's advancements in precision medicine and drug discovery.

    fidelity·
    HK
    09860
    -0.33%
    fidelity·
    HK
    09860
    -0.33%

    Adicon Holdings Files Director List with HKEX

    Adicon Holdings Ltd. has submitted an updated director list to the Hong Kong Stock Exchange, detailing roles and committee memberships. The Board includes Executive Director Mr. Gao Song (CEO), Non-executive Directors Ms. Yang Ling (Chairwoman), Mr. Lin Jixun, Ms. Feng Janine Junyuan, and Mr. Zhou Mintao, along with Independent Non-executive Directors Mr. Mi Brian Zihou, Mr. Yeh Richard, and Mr. Zhang Wei. Various committees are chaired by these directors, overseeing audit, remuneration, nomination, and strategy functions.

    Reuters·
    HK
    09860
    -0.33%
    Reuters·
    HK
    09860
    -0.33%

    ADICON Holdings Announces Director Resignation

    ADICON Holdings Limited announced the resignation of Mr. ZHU Jonathan as a non-executive director and member of the strategy committee, effective November 9, 2025, due to changes in his work arrangement. The company expressed gratitude for his contributions and confirmed no disagreements with shareholders or the Hong Kong Stock Exchange. The latest analyst rating for ADICON Holdings (HK:9860) is a Buy with a price target of HK$8.60.

    Tip Ranks·
    HK
    09860
    -0.33%
    Tip Ranks·
    HK
    09860
    -0.33%

    ADICON Holdings Limited Announces Board Composition and Roles

    ADICON Holdings Limited has announced the composition of its board of directors, detailing the roles of executive, non-executive, and independent non-executive directors, along with their positions in various board committees. This update clarifies the company's leadership structure, which may influence its strategic decisions and operational efficiency. The latest analyst rating for ADICON Holdings (HK:9860) is a Buy, with a price target of HK$8.60.

    Tip Ranks·
    HK
    09860
    -0.33%
    Tip Ranks·
    HK
    09860
    -0.33%